• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The possible role of G-CSF in the pathogenesis of Sweet's syndrome.

作者信息

Reuss-Borst M A, Müller C A, Waller H D

机构信息

Second Department of Internal Medicine, Medical University Clinic, Tübingen, Germany.

出版信息

Leuk Lymphoma. 1994 Oct;15(3-4):261-4. doi: 10.3109/10428199409049722.

DOI:10.3109/10428199409049722
PMID:7532508
Abstract

Sweet's syndrome (SS) is characterized by the clinical features of fever, leucocytosis, neutrophilia and the sudden onset of asymmetric, often very painful skin lesions and dense dermal infiltrates of mature neutrophils without signs of vasculitis. Apart from idiopathic cases the disease is frequently associated with hematological malignancies, but it may also be observed in patients with solid tumors, mainly tumors of the genito-urinary tract. In the past, numerous theories have been proposed to explain the pathogenesis of this rare disease. SS has been interpreted as a direct response to mechanical and chemical irritants, an infectious disease or a disorder of neutrophilic chemotaxis and/or phagocytosis, but most often it has been described as a hypersensitivity reaction. Each of these theories can account for particular symptoms, but none of them reconciles the dominating clinical and laboratory features of the disease. Furthermore recently published casuistic observations suggest the involvement of certain cytokines in particular G-CSF and Il-6 in the pathogenesis of the disease, which might explain many of the observed clinical and laboratory findings. The following article summarizes these data and gives a review of the current literature.

摘要

相似文献

1
The possible role of G-CSF in the pathogenesis of Sweet's syndrome.
Leuk Lymphoma. 1994 Oct;15(3-4):261-4. doi: 10.3109/10428199409049722.
2
Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease.与骨髓发育异常相关的Sweet综合征:细胞因子在该疾病发病机制中的可能作用
Br J Haematol. 1993 Jun;84(2):356-8. doi: 10.1111/j.1365-2141.1993.tb03083.x.
3
Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies and agranulocytosis together with granulocyte colony-stimulating factor induced Sweet's syndrome in a patient with Graves' disease.丙硫氧嘧啶诱发的抗中性粒细胞胞浆抗体及粒细胞缺乏症与粒细胞集落刺激因子共同导致了1例格雷夫斯病患者出现Sweet综合征。
Intern Med. 2011;50(18):1973-6. doi: 10.2169/internalmedicine.50.4483. Epub 2011 Sep 15.
4
Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia.再生障碍性贫血患者接受粒细胞集落刺激因子治疗期间发生Sweet综合征。
Br J Haematol. 1994 Mar;86(3):645-8. doi: 10.1111/j.1365-2141.1994.tb04799.x.
5
[Sweet's syndrome associated with acute myeloid leukemia. Report of one case].[伴急性髓系白血病的Sweet综合征。1例报告]
Rev Med Chil. 2011 Dec;139(12):1592-6. Epub 2012 Mar 7.
6
Sweet's syndrome associated with G-CSF.与粒细胞集落刺激因子相关的Sweet综合征。
Br J Haematol. 1993 Sep;85(1):191-2. doi: 10.1111/j.1365-2141.1993.tb08668.x.
7
[Sweet's syndrome in a patient with chronic myeloproliferative disorder during recombinant human granulocyte colony stimulating factor therapy].[重组人粒细胞集落刺激因子治疗期间慢性骨髓增殖性疾病患者并发Sweet综合征]
Rinsho Ketsueki. 1995 Apr;36(4):353-8.
8
Sweet's syndrome in a severely neutropenic patient during therapy with recombinant human granulocyte colony-stimulating factor.重组人粒细胞集落刺激因子治疗期间一名严重中性粒细胞减少患者发生的Sweet综合征
J Formos Med Assoc. 1997 Apr;96(4):276-9.
9
Sweet's syndrome associated with recurrent fever in a patient with trisomy 8 myelodysplastic syndrome.8号染色体三体骨髓增生异常综合征患者中与反复发热相关的Sweet综合征。
Int J Hematol. 2003 May;77(4):383-6. doi: 10.1007/BF02982648.
10
[Sweet syndrome following therapeutic use of granulocyte colony stimulating factor].[粒细胞集落刺激因子治疗后发生的Sweet综合征]
Orv Hetil. 1999 May 9;140(19):1059-61.

引用本文的文献

1
Clinical features, treatment, and outcome of granulocyte colony stimulating factor-induced sweet syndrome.粒细胞集落刺激因子诱导的嗜中性粒细胞皮肤病的临床特征、治疗和结局。
Arch Dermatol Res. 2024 Oct 14;316(10):685. doi: 10.1007/s00403-024-03414-1.
2
Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies.新冠病毒疫苗引起的Sweet 综合征:患者报告研究的系统评价。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2217076. doi: 10.1080/21645515.2023.2217076.
3
Sweet syndrome in post-COVID-19 infection: A case report.
新型冠状病毒肺炎感染后发生的Sweet综合征:一例报告
Travel Med Infect Dis. 2021 Nov-Dec;44:102188. doi: 10.1016/j.tmaid.2021.102188. Epub 2021 Oct 22.
4
Paraneoplastic syndromes in cholangiocarcinoma.胆管癌中的副肿瘤综合征
World J Hepatol. 2020 Nov 27;12(11):897-907. doi: 10.4254/wjh.v12.i11.897.
5
Insights Into the Pathogenesis of Sweet's Syndrome.Sweet 综合征发病机制的研究进展。
Front Immunol. 2019 Mar 12;10:414. doi: 10.3389/fimmu.2019.00414. eCollection 2019.
6
Sweet's syndrome as a dermatological manifestation of underlying coronary artery disease.Sweet综合征作为潜在冠状动脉疾病的一种皮肤表现。
J Cardiol Cases. 2012 Apr 10;6(1):e8-e12. doi: 10.1016/j.jccase.2012.03.002. eCollection 2012 Jul.
7
Recurrent Sweet's syndrome in a patient with multiple myeloma.一名多发性骨髓瘤患者的复发性Sweet综合征
Clin Case Rep. 2018 Aug 21;6(10):1958-1960. doi: 10.1002/ccr3.1764. eCollection 2018 Oct.
8
Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report.利妥昔单抗治疗慢性淋巴细胞白血病难治性皮下Sweet综合征:一例报告
Mol Clin Oncol. 2016 Mar;4(3):436-440. doi: 10.3892/mco.2015.715. Epub 2015 Dec 18.
9
Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.急性髓系白血病患者中Sweet综合征的特征
Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):358-363. doi: 10.1016/j.clml.2014.12.009. Epub 2014 Dec 24.
10
Unusual Presentation of Idiopathic Sweet's Syndrome in a Photodistributed Pattern.光分布模式的特发性Sweet综合征的不寻常表现
Indian J Dermatol. 2014 Mar;59(2):186-9. doi: 10.4103/0019-5154.127682.